Skip to main content

Month: July 2020

ARHT Media Announces Subscription Bundles To Drive Accelerated Recurring Revenues Powered by the ARHT Engine Software

TORONTO, July 17, 2020 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), is the global leader in the development, production and distribution of high-quality, low latency hologram and digital content.  ARHT is pleased to announce that it is now offering Subscription Bundles that are based on the volume of transmissions that a subscriber requires. The Bundles will lower the per-use cost to the end user and are expected to dramatically increase adoption of the Company’s software platform. The Subscription Bundles can be used to transmit presenters, using the ARHT Engine software, for either in-person hologram events and meetings or for online meetings and events that take place on the Virtual Global StageTM.  Pricing for ARHT’s Holopresence Transmission Bundles are as follows:Bundle 5 – will cost US$15,000...

Continue reading

AMC Networks to Report Second Quarter 2020 Results

NEW YORK, July 17, 2020 (GLOBE NEWSWIRE) — AMC Networks Inc. (NASDAQ: AMCX) will host a conference call to discuss results for the second quarter 2020 on Tuesday, August 4, 2020 at 8:30 a.m. Eastern Time. AMC Networks will issue a press release reporting its results prior to the market opening.The conference call will be webcast live via the company’s website at www.amcnetworks.com under the heading “Investors”. Those parties interested in participating via telephone please dial 877-347-9170 with the conference ID number 3287042 approximately 10 minutes prior to the call.

Continue reading

Outlook Therapeutics Announces Closing of $1.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

MONMOUTH JUNCTION, N.J., July 17, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, today announced the successful closing of its previously announced private placement of 823,045 shares of common stock at a purchase price of $1.215 per share, for aggregate gross proceeds of approximately $1.0 million, to Syntone Ventures LLC, a U.S.-based affiliate of Syntone Technologies Group Co. Ltd.  The securities were priced at-the-market under Nasdaq rules.Outlook Therapeutics intends to use the net proceeds from the financing for working capital and general corporate purposes, including in support of its ONS-5010 development program.The securities described...

Continue reading

Interoil appoints new general manager

Oslo, 17 July 2020Interoil Exploration and Production ASA is pleased to announce the appointment of Mr. Francisco Guillermo Vozza as new General Manager for the company, effective today.Francisco Vozza’s professional background includes more than a decade in corporate strategy and innovation related positions in Equinor, the Norwegian oil, gas and energy company; and a business development role in Scatec Solar, a global leader that builds, owns and operates solar power plants across emerging markets.Francisco Vozza is an Italian-Argentine citizen living in Norway, a graduate from California State University in Los Angeles, and he has an MBA from BI Norwegian School of Management.Mr. Vozza replaces Pablo Creta, who will be pursuing other opportunities outside the company. Mr. Creta also held the position as Chief Financial Officer (CFO)...

Continue reading

LMP Automotive Holdings, Inc. Announces the Acquisition of a 75% Interest in a Southeast Toyota Franchise Dealership

PLANTATION, FL , July 17, 2020 (GLOBE NEWSWIRE) — LMP Automotive Holdings, Inc. (NASDAQ:LMPX) (the “Company” or “LMP”), an e-commerce and facilities-based platform for consumers who desire to buy, sell, subscribe for or finance pre-owned and new automobiles, today announced the acquisition of a 75% interest in a Southeast Toyota Franchise Dealership.Brian Finnegan, the Company’s Executive Manager in charge of franchise dealership management stated,“It’s LMP’s vision to continue the legacy of the dealer and it’s online presence while providing our e-commerce solutions and offerings, financial strength, business acumen and sophistication of LMP to help grow the business.”Sam Tawfik, the Company’s Chairman and Chief Executive Officer stated,Mr. Tawfik also added,“We are also focused on adding additional executive management...

Continue reading

AMERISAFE Named to Ward’s Property-Casualty Top Performers List for 12th Year

DERIDDER, La., July 17, 2020 (GLOBE NEWSWIRE) — AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers’ compensation insurance focused on high hazard industries, today announced the Company has been named to the Ward’s 50 top performing property-casualty companies for the 12th consecutive year.  This year’s award recognizes outstanding financial results in the areas of safety, consistency, and performance over the five-year period from 2015-2019. Janelle Frost, President and CEO, said, “We are honored to be recognized for our financial strength and stability.  This award affirms our dedication to quality, long-term service, and I congratulate the AMERISAFE team on this recognition.”   About AMERISAFEAMERISAFE, Inc. is a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged...

Continue reading

Cidara Therapeutics to Participate in B. Riley Virtual Summer Series Panel on Antiviral Therapeutics

SAN DIEGO, July 17, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will participate in the B. Riley FBR Virtual Summer Series panel on antiviral therapeutics on Tuesday, July 21, 2020.If you are an institutional investor and would like to register to participate in this event, please contact Brian Ritchie of LifeSci Advisors at britchie@lifesciadvisors.com.About Cidara TherapeuticsCidara is developing therapeutics to improve the standard of care for patients facing severe fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming...

Continue reading

Uxin to Report Financial Results for the Quarter Ended March 31, 2020 on July 24, 2020

BEIJING, July 17, 2020 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used car dealer in China, today announced that it will report its unaudited financial results for the quarter ended March 31, 2020 before the open of U.S. markets on July 24, 2020. On April 26, 2020, Uxin’s board of directors approved a change of fiscal year end from December 31 to March 31. Uxin’s management team will host a conference call on Friday, July 24, 2020 at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing/Hong Kong time on the same day).Due to the outbreak of COVID-19, operator assisted conference calls are not available at the moment. All participants must preregister online prior to the call to receive the dial-in details.Conference Call PreregistrationParticipants can register for the conference call...

Continue reading

Aura Minerals Announces Preliminary Second Quarter 2020 Operational Results

ROAD TOWN, British Virgin Islands, July 17, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (“Aura” or the “Company”) today announces preliminary operational results for the second quarter of 2020.The second quarter of 2020 was impacted by the new Coronavirus (COVID-19), which was declared a pandemic (the “Pandemic”) by the World Health Organization on March 11, 2020.As previously announced, the Company and its subsidiaries have prioritized the safety of its employees and the communities around which Aura operates during the Pandemic and have implemented protective measures and biosafety protocols during this period in addition to expanding Aura’s social work with local communities, including donations of food, medicine and medical supplies.From an operational perspective, also as previously announced, the Pandemic...

Continue reading

Hartford Great Health Announces Increased Investment to Subsidiary and New Cooperation Agreement With Shanghai JiaoTong University

ROSEMEAD, Calif, July 17, 2020 (GLOBE NEWSWIRE) — Hartford Great Health Corp. (“Hartford” or the “Company”) (HFUS), a company focus on the development of the Sino-U.S. health industry, today announced Hartford Great Health Management (Shanghai) Ltd. (“HFSH”), the subsidiary of the Company, has invested additional 4.5 million Chinese Yuan (approximately $630,000 US dollar) to Hartford International Education Technology (Shanghai) Co. Ltd.  (“HFIE”), the subsidiary of HFSH on 6/1/2020. HFSH will hold 75.5% of HFIE after the investment. The main business of HFIE focus on early children education and children’s mental health. In addition, HFIE has successfully signed a Cooperation Agreement (the “Agreement”) with Shanghai JiaoTong University (“SJU”) on June 5, 2020 who is a famous university located in Shanghai, China.“I am very...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.